Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COPD Disease Burden, Patient Characteristics, Maintenance Treatment Patterns and Factors Influencing Treatment Decisions in China Tier 2 and Tier 3 Hospitals

NCT04853238 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT04853238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04853238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COPD Disease Burden, Patient Characteristics, Maintenance Treatment Patterns and Factors Influencing Treatment Decisions in China Tier 2 and Tier 3 Hospitals
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
April 27, 2021
Completion date
February 6, 2023
Enrollment
1,507 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease, chronic obstructive